John W. Childs, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 10,000 shares at $40.37 ($404K) on 2019-06-26, disclosed to the SEC on 2019-06-26.
Open-market purchase of $404k BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MANE | BUY | 2026-02-05 | $5.0M | — | Filing → |
| BHVN | BUY | 2025-11-17 | $50.0M | — | Filing → |
| BHVN | BUY | 2025-03-05 | $892K | — | Filing → |